Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 201
Filtrar
1.
Cell Biochem Funct ; 34(6): 455-62, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27558076

RESUMEN

OBJECTIVE: Studies indicate that bupivacaine-induced neurotoxicity results from apoptosis. Gangliosides have been shown to promote neuronal repair and recovery of neurological function after spinal cord injury. Previously, we confirmed that in vivo administration of the ganglioside GM-1 attenuated bupivacaine-induced neurotoxicity in various animal models; however, the underlying mechanism remains unclear. METHODS: Cells of the neuroblastoma line N2a (Neuro2a cells) were divided into three experimental groups: control, bupivacaine-treated, and bupivacaine-treated with GM-1 pretreatment. Cell viability and apoptosis were assessed through CCK-8 assays, Hoechst staining, and flow cytometry analysis of Annexin-V/propidium iodide double labeling. Real-time polymerase chain reaction and western blotting assessed the expression of caspase-3, caspase-8, and caspase-9. RESULTS: Bupivacaine-induced apoptosis worsened with increasing dose and exposure time. Bupivacaine induced increased expression of caspase-3 and caspase-9, but not caspase-8, indicating that the mitochondrial pathway but not the death receptor apoptosis pathway was activated. GM-1 pretreatment inhibited bupivacaine-induced apoptosis and the expression of caspase-3 and caspase-9 in a dose-dependent manner. CONCLUSION: Bupivacaine induced neurotoxicity by activating apoptosis via the mitochondrial pathway, and this was inhibited by GM-1 pretreatment.


Asunto(s)
Bupivacaína/toxicidad , Gangliósido G(M1)/farmacología , Neuroblastoma/patología , Neurotoxinas/toxicidad , Animales , Apoptosis/efectos de los fármacos , Bisbenzimidazol/metabolismo , Western Blotting , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Citometría de Flujo , Ratones , Neuroprotección/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa
2.
Mol Pharmacol ; 88(4): 768-78, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26240287

RESUMEN

Radiotherapy, a therapeutic modality of cancer treatment, nonselectively damages normal tissues as well as tumor tissues. The search is ongoing for therapeutic agents that selectively reduce radiation-induced normal tissue injury without reducing tumoricidal effect, thereby increasing the therapeutic ratio of radiation therapy. Our laboratory established 5-(4-methylpiperazin-1-yl)-2-[2'-(3,4-dimethoxyphenyl)-5'benzimidazolyl] benzimidazole (DMA) as noncytotoxic radioprotector in mammalian cells. DMA showed an excellent radioprotection in mice at single nontoxic oral dose by a dose-reduction factor of 1.28. An oxygen radical absorbing capacity assay confirmed its free-radical quenching ability. Single bolus dose and 28-days of repeated administration of DMA in mice for toxicity studies determined an LD50 of >2000 mg/kg body weight (bw) and 225 mg/kg bw, respectively, suggesting DMA is safe. Histopathology, biochemical parameters, and relative organ weight analysis revealed insignificant changes in the DMA-treated animals. The pharmacokinetic study of DMA at oral and intravenous doses showed its C(max) = 1 hour, bioavailability of 8.84%, elimination half-life of 4 hours, and an enterohepatic recirculation. Biodistribution study in mice with Ehrlich ascites tumors showed that (99m)Tc-DMA achieved its highest concentration in 1 hour and was retained up to 4 hours in the lungs, liver, kidneys, and spleen, and in a low concentration in the tumor, a solicited property of any radioprotector to protect normal cells over cancerous cells. We observed that the single-dose treatment of tumor-bearing mice with DMA 2 hours before 8 Gy total body irradiation showed an impressive rescue of radiation-induced morbidity in terms of weight loss and mortality without a change in tumor response.


Asunto(s)
Bencimidazoles/farmacocinética , Bencimidazoles/toxicidad , Piperazinas/farmacocinética , Piperazinas/toxicidad , Protectores contra Radiación/farmacocinética , Protectores contra Radiación/toxicidad , Animales , Bencimidazoles/metabolismo , Bisbenzimidazol/metabolismo , Bisbenzimidazol/farmacocinética , Bisbenzimidazol/toxicidad , Carcinoma de Ehrlich/tratamiento farmacológico , Carcinoma de Ehrlich/metabolismo , Carcinoma de Ehrlich/radioterapia , Relación Dosis-Respuesta en la Radiación , Evaluación Preclínica de Medicamentos/métodos , Femenino , Células HEK293 , Humanos , Masculino , Ratones , Ratones Endogámicos BALB C , Piperazinas/metabolismo , Protectores contra Radiación/metabolismo , Tasa de Supervivencia/tendencias , Distribución Tisular/efectos de los fármacos , Distribución Tisular/fisiología
3.
J Fluoresc ; 24(6): 1791-801, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25312832

RESUMEN

DNA-bound Hoechst 33258 is readily excited with UV light and emits blue fluorescence, however, upon exposure to UV, the dye undergoes photobleaching as well as photoconversion to a blue-excited green-emitting form. We demonstrate that the UV-generated green-emitting form of Hoechst 33258 exhibits spectral properties very similar to the form of the dye that can be obtained by subjecting it to an acidic environment (pH 0.5-3.0). We also demonstrate that exposure of Hoechst 33258 to UV light (or hydrogen peroxide) leads to generation of the protonated (1+, 2+, 3+ and possibly the 4+) forms of the dye. Photoconversion of Hoechst 33258 has recently been exploited in single molecule localisation microscopy, thus understanding photophysics of this process can facilitate further development of high resolution optical imaging.


Asunto(s)
Bisbenzimidazol/química , ADN/química , Colorantes Fluorescentes/química , Rayos Ultravioleta , Bisbenzimidazol/metabolismo , Bisbenzimidazol/efectos de la radiación , Células Cultivadas , ADN/metabolismo , ADN/efectos de la radiación , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Colorantes Fluorescentes/metabolismo , Colorantes Fluorescentes/efectos de la radiación , Humanos , Peróxido de Hidrógeno/farmacología , Concentración de Iones de Hidrógeno , Microscopía Fluorescente , Oxidantes/farmacología , Protones , Espectrometría de Masa por Ionización de Electrospray
4.
Microbiol Spectr ; 12(4): e0407223, 2024 Apr 02.
Artículo en Inglés | MEDLINE | ID: mdl-38376353

RESUMEN

We previously identified the bisbenzimide Hoechst 33342 (H42) as a potent multi-stage inhibitor of the prototypic poxvirus, the vaccinia virus (VACV), and several parapoxviruses. A recent report showed that novel bisbenzimide compounds similar in structure to H42 could prevent human cytomegalovirus replication. Here, we assessed whether these compounds could also serve as poxvirus inhibitors. Using virological assays, we show that these bisbenzimide compounds inhibit VACV spread, plaque formation, and the production of infectious progeny VACV with relatively low cell toxicity. Further analysis of the VACV lifecycle indicated that the effective bisbenzimide compounds had little impact on VACV early gene expression but inhibited VACV late gene expression and truncated the formation of VACV replication sites. Additionally, we found that bisbenzimide compounds, including H42, can inhibit both monkeypox and a VACV mutant resistant to the widely used anti-poxvirus drug TPOXX (Tecovirimat). Therefore, the tested bisbenzimide compounds were inhibitors of both prototypic and pandemic potential poxviruses and could be developed for use in situations where anti-poxvirus drug resistance may occur. Additionally, these data suggest that bisbenzimide compounds may serve as broad-activity antiviral compounds, targeting diverse DNA viruses such as poxviruses and betaherpesviruses.IMPORTANCEThe 2022 mpox (monkeypox) outbreak served as a stark reminder that due to the cessation of smallpox vaccination over 40 years ago, most of the human population remains susceptible to poxvirus infection. With only two antivirals approved for the treatment of smallpox infection in humans, the need for additional anti-poxvirus compounds is evident. Having shown that the bisbenzimide H33342 is a potent inhibitor of poxvirus gene expression and DNA replication, here we extend these findings to include a set of novel bisbenzimide compounds that show anti-viral activity against mpox and a drug-resistant prototype poxvirus mutant. These results suggest that further development of bisbenzimides for the treatment of pandemic potential poxviruses is warranted.


Asunto(s)
Poxviridae , Viruela , Humanos , Bisbenzimidazol/metabolismo , Pandemias , Virus Vaccinia/genética
5.
Cytometry A ; 83(5): 441-51, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23418106

RESUMEN

Hoechst 33258, DAPI and Vybrant DyeCycle are commonly known DNA fluorescent dyes that are excited by UV and emit in the blue region of the spectrum of visible light. Conveniently, they leave the reminder of the spectrum for microscopy detection of other cellular targets labeled with probes emitting in green, yellow or red. However, an exposure of these dyes to UV induces their photoconversion and results in production of the forms of these dyes that are excited by blue light and show fluoresce maxima in green and a detectable fluorescence in yellow and orange regions of the spectrum. Photoconversion of Hoechst 33258 and DAPI is reversible and independent of the dye concentration or the presence of DNA. Spectrofluorimetry and mass spectrometry analyses indicate that exposure to UV induces protonation of Hoechst 33258 and DAPI.


Asunto(s)
Bisbenzimidazol/efectos de la radiación , Colorantes Fluorescentes/efectos de la radiación , Indoles/efectos de la radiación , Luz , Microscopía Fluorescente/métodos , Protones , Rayos Ultravioleta , Bisbenzimidazol/metabolismo , Línea Celular , Células Cultivadas , Color , Relación Dosis-Respuesta en la Radiación , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Colorantes Fluorescentes/metabolismo , Humanos , Peróxido de Hidrógeno/farmacología , Concentración de Iones de Hidrógeno , Indoles/metabolismo , Espectrometría de Masas , Espectrometría de Fluorescencia
6.
Bioorg Med Chem Lett ; 23(20): 5689-93, 2013 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-24012122

RESUMEN

Synthesis of a novel class of compounds and their biophysical studies with TAR-RNA are presented. The synthesis of these compounds was achieved by conjugating neomycin, an aminoglycoside, with benzimidazoles modeled from a B-DNA minor groove binder, Hoechst 33258. The neomycin-benzimidazole conjugates have varying linkers that connect the benzimidazole and neomycin units. The linkers of varying length (5-23 atoms) in these conjugates contain one to three triazole units. The UV thermal denaturation experiments showed that the conjugates resulted in greater stabilization of the TAR-RNA than either neomycin or benzimidazole used in the synthesis of conjugates. These results were corroborated by the FID displacement and tat-TAR inhibition assays. The binding of ligands to the TAR-RNA is affected by the length and composition of the linker. Our results show that increasing the number of triazole groups and the linker length in these compounds have diminishing effect on the binding to TAR-RNA. Compounds that have shorter linker length and fewer triazole units in the linker displayed increased affinity towards the TAR RNA.


Asunto(s)
Bencimidazoles/química , Neomicina/química , ARN Viral/metabolismo , Bisbenzimidazol/química , Bisbenzimidazol/metabolismo , Dicroismo Circular , Duplicado del Terminal Largo de VIH , VIH-1/genética , Humanos , Ligandos , ARN Viral/química , Productos del Gen tat del Virus de la Inmunodeficiencia Humana/antagonistas & inhibidores , Productos del Gen tat del Virus de la Inmunodeficiencia Humana/metabolismo
7.
Cell Physiol Biochem ; 29(3-4): 485-92, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22508055

RESUMEN

AIMS: The study was aimed to investigate whether nicotine affects endothelial expression of PTHrP and PTHrP receptor, a peptide system involved in endothelial protection against apoptosis. METHODS: Isolated and cultured rat coronary endothelial cells were used. Immunoblot techniques were used to study activation of mitogen-activated protein (MAP) kinases and to quantify PTHrP and PTHrP receptor expression. Real-time RT-PCR was used to quantify PTHrP, PTHrP-receptor, bcl-2, and bax mRNA expression. The rate of apoptosis was determined by HOE33258 staining and confirmed by quantification of the bcl-2-to-bax ratio. In vitro data were compared to hearts from rats exposed to cigarette smoking. RESULTS: Nicotine induced PTHrP protein expression at nanomolar levels and small increases of PTHrP release (≈8%). Antagonists directed against the α7 subunit of cholinergic receptors, the most prominent isoform, attenuated nicotine-dependent increases of PTHrP expression. This effect of nicotine was p38 MAPK dependent. Nicotine at micromolar concentrations reduced PTHrP receptor expression. In vitro and in vivo we found a correlation between PTHrP receptor expression and bcl-2 expression. CONCLUSION: Nicotine induces PTHrP expression in endothelial cells but excessive concentrations of nicotine reduce PTHrP receptor expression thereby attenuating any protective effects of PTHrP against apoptosis.


Asunto(s)
Células Endoteliales/efectos de los fármacos , Nicotina/farmacología , Proteína Relacionada con la Hormona Paratiroidea/metabolismo , Receptor de Hormona Paratiroídea Tipo 1/efectos de los fármacos , Animales , Apoptosis , Bisbenzimidazol/metabolismo , Bungarotoxinas/farmacología , Células Cultivadas , Células Endoteliales/metabolismo , Células Endoteliales/patología , Activación Enzimática , Flavonoides/farmacología , Corazón/efectos de los fármacos , Imidazoles/farmacología , Immunoblotting , Sistema de Señalización de MAP Quinasas , Masculino , Piridinas/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Receptor de Hormona Paratiroídea Tipo 1/antagonistas & inhibidores , Receptor de Hormona Paratiroídea Tipo 1/metabolismo , Fumar/efectos adversos , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
8.
Cell Mol Neurobiol ; 31(2): 303-11, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21063768

RESUMEN

Glutamate, one of the major neurotransmitters in the central nervous system, is released into the synaptic spaces and bound to the glutamate receptors which facilitate normal synaptic transmission, synaptic plasticity, and brain development. Past studies have shown that glutamate with high concentration is a potent neurotoxin capable of destroying neurons through many signal pathways. In this research, our main purpose was to determine whether the specific soluble guanylyl cyclase activator YC-1 (3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole) had effect on glutamate-induced apoptosis in cultured PC12 cells. The differentiated PC12 cells impaired by glutamate were used as the cell model of excitability, and were exposed to YC-1 or/and ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) with gradient concentrations for 24 h. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl) assay was used to detect the cellular viability. Radioimmunoassay (RIA) was used to detect the cGMP (cyclic guanosine monophosphate) concentrations in PC12 cells. Hoechst 33258 staining and flow cytometric analysis were used to detect the cell apoptosis. The cellular viability was decreased and the apoptotic rate was increased when PC12 cells were treated with glutamate. Cells treated with YC-1 or/and ODQ showed no significant differences in the cell viability and intracellular cGMP levels compared with those of control group. The specific soluble guanylyl cyclase (sGC) inhibitor ODQ showed an inhibitory effect on cGMP level and aggravated the apoptosis of PC12 cells induced by glutamate. YC-1 elevated cGMP level thus decreased PC12 cell apoptosis induced by glutamate, but this effect could be reversed by ODQ. These results revealed that YC-1 might attenuate glutamate-induced PC12 cell apoptosis via a sGC-cGMP involved pathway.


Asunto(s)
Apoptosis/efectos de los fármacos , Glutamatos/toxicidad , Indazoles/farmacología , Sustancias Protectoras/farmacología , Animales , Bisbenzimidazol/metabolismo , Forma de la Célula/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , GMP Cíclico/biosíntesis , Sinergismo Farmacológico , Oxadiazoles/farmacología , Células PC12 , Quinoxalinas/farmacología , Ratas , Coloración y Etiquetado
9.
Cell Mol Neurobiol ; 31(3): 351-6, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21191645

RESUMEN

The cell adhesion molecule Tag-1 is highly expressed in immature cerebellar granule neurons (CGNs) during axonogenesis and is down-regulated prior to onset of radial migration. However, its precise role(s) during development of mammalian CGNs has been unclear. Here we studied the effects of anti-Tag-1 function blocking antibodies on the development of mouse CGNs in primary cell culture and in situ. Interfering antibodies inhibited axon formation by mouse CGNs in both cell cultures and in cerebellar slices. Effects on axon extension in cell cultures were observed under conditions of homotypic cell-cell contact, consistent with inhibition of cell adhesion activity. Further, when used as a substratum Tag-1 protein strongly stimulated neurite outgrowth by CGNs. Antagonism of Tag-1 also enhanced CGN migration in modified Boyden chamber assays. Radial migration was inhibited by Tag-1 antibodies in cerebellar slices, possibly reflecting a block in early CGN maturation in situ. These findings are consistent with a regulatory role for Tag-1 in axon emergence as well as migratory behavior by developing mouse CGNs.


Asunto(s)
Cerebelo/citología , Contactina 2/metabolismo , Neuronas/fisiología , Animales , Bisbenzimidazol/metabolismo , Movimiento Celular/fisiología , Células Cultivadas , Cerebelo/crecimiento & desarrollo , Contactina 2/genética , Colorantes Fluorescentes/metabolismo , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Humanos , Ratones , Neuronas/citología
10.
Mol Cell Biochem ; 358(1-2): 95-104, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21691772

RESUMEN

Apoptosis is a genetically regulated cellular suicide mechanism that plays an essential role in development and in defense of multicellular organism. Escherichia coli (E. coli) can induce monocyte apoptosis; however, the mechanism is not clear. This study determines if Fas/FasL regulates E. coli-induced human monocyte line U937 cell apoptosis. We found that infection of U937 cells with E. coli induced rapid cell death in a dose- and time-dependent manner displaying the characteristic features of apoptosis. Moreover, opsonized E. coli induced U937 apoptosis with a higher apoptotic rate (53.29 ± 5.83%) than non-opsonized E. coli (19.37 ± 2.56%). Studying the underlying mechanisms we found that the E. coli-induced apoptosis was associated with a more prominent induction expression of Fas/FasL in a time- and dose-dependent manner. Furthermore, E. coli treatment resulted in a significant increase in the levels of DR5, TRAIL, and FADD, but exerted no statistically significant effects on the levels of DR4. The activity of caspase-8 enzyme increased in infection groups, positively correlated with apoptosis rate. Taken together, these results clearly indicate that receptor-mediated phagocytosis of E. coli induces apoptosis. Moreover, our findings suggest a possible regulatory role of Fas/FasL in the pathway of E. coli infection.


Asunto(s)
Apoptosis , Escherichia coli/metabolismo , Proteína Ligando Fas/metabolismo , Monocitos/citología , Monocitos/microbiología , Transducción de Señal , Receptor fas/metabolismo , Apoptosis/efectos de los fármacos , Bisbenzimidazol/metabolismo , Caspasa 8/metabolismo , Inhibidores de Caspasas , Proteína Ligando Fas/genética , Humanos , Ligandos , Monocitos/efectos de los fármacos , Proteínas Opsoninas/metabolismo , Fagocitosis/efectos de los fármacos , Inhibidores de Proteasas/farmacología , Receptores de Muerte Celular/metabolismo , Transducción de Señal/efectos de los fármacos , Células U937 , Receptor fas/genética
11.
Genet Mol Res ; 10(4): 3747-59, 2011 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-22179998

RESUMEN

An electrochemical biosensor, using a disposable electrochemical printed chip aggregation by the bisbenzimide dye (Hoechst 33258), was used for detecting the expression of ß-actin and RAGE genes. Using linear sweep voltammetry, the expression of these two genes in HeLa and HepG2 cell lines was determined based on anodic peak current, and the results were compared with conventional agarose gel electrophoresis. Total cellular RNA was reverse transcribed to complementary DNA, and amplification by PCR was carried out. Subsequently, the PCR products were subjected to detection by either electrophoresis or electrochemical biosensor. Precision of the electrochemical biosensor technique was acceptable (ß-actin: CV = 1.875% for 10(4) copies and 4.684% for 10(9) copies; RAGE: CV = 2.253% for 10(9) copies, and 3.743% for 10 copies). In the electrochemical biosensor technique, the PCR products were measured in the same run with various concentrations of standards, and copy numbers of ß-actin gene were interpolated from a standard curve. Copy numbers of the ß-actin gene were then compared between the two techniques. At the 95% confidence limit, the two methods had no significant differences and were significantly correlated (y = -40383.0623 + 1.0233x; P > 0.10). The electrochemical biosensor method was more sensitive than the conventional electrophoresis method because it could detect as low as 10 copies of the RAGE gene. The conventional electrophoresis method detected the RAGE gene at concentrations of at least 10(4) copies, and the linearity for semi-quantitative measurement was in the range of 10(6)-10(9) copies. When the electrochemical biosensor was applied to detect the RAGE gene expression in both cell types, we found that HeLa cells expressed the RAGE gene about 2-fold higher than in HepG2 cells (relative value of 0.000905 vs 0.0004670). Therefore, this study suggests the potential modification of the electrochemical biosensor with the use of bisbenzimide dye (Hoechst 33258) for detecting gene expression.


Asunto(s)
Bisbenzimidazol/metabolismo , Colorantes/metabolismo , Técnicas Electroquímicas/métodos , Regulación Neoplásica de la Expresión Génica , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Actinas/genética , Técnicas Biosensibles , Electrodos , Electroforesis en Gel de Agar , Dosificación de Gen/genética , Células HeLa , Células Hep G2 , Humanos , Reacción en Cadena de la Polimerasa , Receptor para Productos Finales de Glicación Avanzada/genética , Estándares de Referencia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/normas
12.
Parasitology ; 137(12): 1791-7, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20561394

RESUMEN

The use of chemotherapy on a mass scale in endemic areas may lead to the appearance of resistant isolates through the mechanism of selective drug pressure. Studies have demonstrated that praziquantel (PZQ) is able to inhibit the excretory activity and to cause tegumental damage in Schistosoma mansoni adult worms. The use of the probe resorufin to evaluate excretory activity, as well as the probe Hoechst 33258 to detect tegumental damage in adult worms, may represent a method to identify resistant (or less susceptible) isolates. The purpose of the present work was to compare the changes caused by PZQ in the function of the excretory system and in the integrity of the tegument of adult worms from the LE isolate (susceptible to PZQ) and the LE-PZQ isolate (less susceptible to PZQ). Worms from the isolate LE-PZQ showed less severe tegumental lesions, in both in vitro and in vivo experiments, detected by labelling with Hoechst 33258 and continued to have a functional excretory system as shown by labelling with resorufin in vitro.


Asunto(s)
Antihelmínticos/farmacología , Resistencia a Medicamentos , Colorantes Fluorescentes , Praziquantel/farmacología , Schistosoma mansoni/efectos de los fármacos , Animales , Bisbenzimidazol/metabolismo , Sistema Digestivo/metabolismo , Sistema Digestivo/patología , Colorantes Fluorescentes/metabolismo , Oxazinas/metabolismo , Pruebas de Sensibilidad Parasitaria/métodos , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/parasitología , Piel/metabolismo , Piel/patología
13.
Med Sci Monit ; 16(9): BR307-12, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20802407

RESUMEN

BACKGROUND: The present study analyzed the neuroprotective effects of topiramate on 6-hydroxydopamine (6-OHDA)-induced toxicity in primary dopaminergic mesencephalic neuronal cell cultures. MATERIAL/METHODS: Through the use of tyrosine hydroxylase and microtubule-associated protein 2 immunocytochemistry, the morphology and development of dopaminergic neurons was observed. Hoechst33258 and propidium iodide (PI) double staining was used to determine cell membrane penetrability and apoptosis by fluorescent microscopy. Methyl thiazole tetrazolium was used to assay cell viability and metabolism. The cells were assigned to 3 groups: (1) control: primary cultured neurons; (2) 6-OHDA: primary cultured neurons and 6-OHDA; and (3) topiramate (TPM) protection: primary cultured neurons and 6-OHDA, treated with various concentrations (10, 50, and 100 microM) of TPM. RESULTS: Hoechst 33258 and PI double immunofluorescence revealed that the number of dying cells after 6-OHDA treatment was greater than after TPM treatment. Compared with the 6-OHDA group, there were more neurons with greater cell viability in the 6-OHDA plus TPM group. CONCLUSIONS: Topiramate was shown to provide protection to dopaminergic neurons exposed to 6-OHDA by reducing cell apoptosis and enhancing cell viability. The neuroprotective effects of TPM were dose-dependent.


Asunto(s)
Dopamina/metabolismo , Fructosa/análogos & derivados , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Animales , Bisbenzimidazol/metabolismo , Recuento de Células , Muerte Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Forma de la Célula/efectos de los fármacos , Técnica del Anticuerpo Fluorescente , Formazáns/metabolismo , Fructosa/farmacología , Proteínas Asociadas a Microtúbulos/metabolismo , Neuronas/citología , Neuronas/enzimología , Neuronas/metabolismo , Propidio/metabolismo , Ratas , Ratas Sprague-Dawley , Coloración y Etiquetado , Sales de Tetrazolio/metabolismo , Topiramato , Tirosina 3-Monooxigenasa/metabolismo
14.
Mol Biol (Mosk) ; 44(4): 718-27, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-20873232

RESUMEN

HIV-1 integrase is responsible for one of the key steps of the viral replication, integration of the viral cDNA into the host cell genome. Integration inhibition leads to complete block of the virus replication. In this study inhibition of integration by dimeric bisbenzimidazoles DBBI(7) with heptamethylene and DBBI(8) with tri(ethylene glycol) spacers was examined, and it was learned out that IC50 for DBBI(7) was about 0.03 microM, and IC50 for DBBI(8) was about 10 microM. By using cross-linking assays, it was shown that both compounds impeded a proper disposition of DNA-substrate at the active centre of integrase. Dissociation constants for complexes between either DBBI and DNA-substrate of integrase were determined. Calculated Kd values were 270 nM and 140 nM for complexes formed by DBBI(7) and DBBI(8), respectively. Therefore, inhibition of integration does not directly result from the binding of DBBIs with DNA. The dependence of initial rates of enzymatic reaction on the DNA-substrate concentration in presence of different concentrations of inhibitors was found, and inhibition constants were determined. All the data obtained allow us to suppose that the different inhibition activity of DBBI(7) and DBBI(8) results from the different mechanism of their binding: DBBI(7) is a competitive inhibitor of integrase whereas DBBI(8) is assumed to show a more complex mechanism of inhibition.


Asunto(s)
Bisbenzimidazol/química , ADN/química , Inhibidores de Integrasa VIH/química , Integrasa de VIH/química , VIH-1/enzimología , Bisbenzimidazol/análogos & derivados , Bisbenzimidazol/metabolismo , Dominio Catalítico , ADN/metabolismo , Integrasa de VIH/metabolismo , Cinética , Unión Proteica
15.
Commun Biol ; 3(1): 525, 2020 09 22.
Artículo en Inglés | MEDLINE | ID: mdl-32963293

RESUMEN

Understanding the dynamic interactions of ligands to DNA is important in DNA-based nanotechnologies. By structurally tracking the dissociation of Hoechst 33258-bound DNA (d(CGCAAATTTGCG)2) complex (H-DNA) with T-jump 2D-IR spectroscopy, the ligand is found to strongly disturb the stability of the three C:G base pairs adjacent to A:T the binding site, with the broken base pairs being more than triple at 100 ns. The strong stabilization effect of the ligand on DNA duplex makes this observation quite striking, which dramatically increases the melting temperature and dissociation time. MD simulations demonstrate an important role of hydration water and counter cations in maintaining the separation of terminal base pairs. The hydrogen bonds between the ligand and thymine carbonyls are crucial in stabilizing H-DNA, whose breaking signal appearing prior to the complete dissociation. Thermodynamic analysis informs us that H-DNA association is a concerted process, where H cooperates with DNA single strands in forming H-DNA.


Asunto(s)
Bisbenzimidazol/metabolismo , ADN/metabolismo , Sitios de Unión , Roturas del ADN/efectos de los fármacos , Enlace de Hidrógeno , Desnaturalización de Ácido Nucleico , Espectroscopía Infrarroja por Transformada de Fourier , Termodinámica
16.
Biophys Chem ; 256: 106270, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31706136

RESUMEN

DNA strands can be designed to assemble into stable three-dimensional structures, based on Watson-Crick base pairing rules. The simplest of these is the DNA tetrahedron that is composed of four oligonucleotides. We have re-designed the sequence of a DNA tetrahedron so that it contains a single (AATT) binding site for the minor groove binding ligand Hoechst 33258. We examined the stability of this structure by placing fluorescent groups within each of its edges and have shown that all the edges melt at the same temperature in the absence of the ligand. The minor groove ligand still binds to its recognition sequence within the tetrahedron and increases the melting temperature of the folded complex. This ligand-induced stabilisation is propagated into the adjacent helical arms and the tetrahedron melts as a single entity in a cooperative fashion.


Asunto(s)
ADN/química , Ligandos , Secuencia de Bases , Sitios de Unión , Bisbenzimidazol/química , Bisbenzimidazol/metabolismo , Conformación de Ácido Nucleico , Transición de Fase/efectos de la radiación , Espectrometría de Fluorescencia , Temperatura de Transición , Rayos Ultravioleta
17.
J Am Chem Soc ; 131(28): 9767-79, 2009 Jul 22.
Artículo en Inglés | MEDLINE | ID: mdl-19552411

RESUMEN

Herein, we describe the design of high affinity ligands that bind expanded rCUG and rCAG repeat RNAs expressed in myotonic dystrophy type 1 (DM1) and spinocerebellar ataxia type 3. These ligands also inhibit, with nanomolar IC(50) values, the formation of RNA-protein complexes that are implicated in both disorders. The expanded rCUG and rCAG repeats form stable RNA hairpins with regularly repeating internal loops in the stem and have deleterious effects on cell function. The ligands that bind the repeats display a derivative of the bisbenzimidazole Hoechst 33258, which was identified by searching known RNA-ligand interactions for ligands that bind the internal loop displayed in these hairpins. A series of 13 modularly assembled ligands with defined valencies and distances between ligand modules was synthesized to target multiple motifs in these RNAs simultaneously. The most avid binder, a pentamer, binds the rCUG repeat hairpin with a K(d) of 13 nM. When compared to a series of related RNAs, the pentamer binds to rCUG repeats with 4.4- to >200-fold specificity. Furthermore, the affinity of binding to rCUG repeats shows incremental gains with increasing valency, while the background binding to genomic DNA is correspondingly reduced. Then, it was determined whether the modularly assembled ligands inhibit the recognition of RNA repeats by Muscleblind-like 1 (MBNL1) protein, the expanded-rCUG binding protein whose sequestration leads to splicing defects in DM1. Among several compounds with nanomolar IC(50) values, the most potent inhibitor is the pentamer, which also inhibits the formation of rCAG repeat-MBNL1 complexes. Comparison of the binding data for the designed synthetic ligands and MBNL1 to repeating RNAs shows that the synthetic ligand is 23-fold higher affinity and more specific to DM1 RNAs than MBNL1. Further studies show that the designed ligands are cell permeable to mouse myoblasts. Thus, cell permeable ligands that bind repetitive RNAs have been designed that exhibit higher affinity and specificity for binding RNA than natural proteins. These studies suggest a general approach to targeting RNA, including those that cause RNA dominant disease.


Asunto(s)
Diseño de Fármacos , Enfermedad de Machado-Joseph/tratamiento farmacológico , Enfermedad de Machado-Joseph/genética , Distrofia Miotónica/tratamiento farmacológico , Distrofia Miotónica/genética , ARN Mensajero/metabolismo , Expansión de Repetición de Trinucleótido/genética , Animales , Secuencia de Bases , Bisbenzimidazol/análogos & derivados , Bisbenzimidazol/metabolismo , Bisbenzimidazol/farmacología , Bisbenzimidazol/uso terapéutico , Línea Celular , Humanos , Concentración 50 Inhibidora , Secuencias Invertidas Repetidas/genética , Ligandos , Ratones , Permeabilidad , Unión Proteica/efectos de los fármacos , ARN Mensajero/genética , Proteínas de Unión al ARN/metabolismo , Reproducibilidad de los Resultados , Especificidad por Sustrato
18.
Cytogenet Genome Res ; 124(1): 106-11, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19372676

RESUMEN

Synchronized peripheral blood lymphocytes from both river buffalo (BBU) and sheep (OAR) were treated for late incorporation of both BrdU and H-33258 to obtain R-banded preparations to be used for FISH-mapping. Ovine BAC-clones were hybridized for three days on slides pre-exposed to UV light after H-33258 staining. The following loci were mapped: GPR103 (BBU7q13, OAR6q13), TRAM1L1(OAR6q13dist), PPP3CA (BBU7q21, OAR6q15), SNCA (OAR6q17), PPARGC1A(BBU7q23, OAR6q17), UGDH (BBU7q25prox, OAR6q22prox), KDR (BBU7q27, OAR6q22), CNOT6L (BBU7q32prox, OAR6q32prox), NUP54 (BBU7q32, BBU6q32), DMP1 (BBU7q34dist-q36prox, OAR6q34dist-q36prox), QDPR (BBU7q36, OAR6q36). All loci mapped in homoeologous chromosomes and chromosome bands of the two species and their locations are in agreement with the previous RH-mapping performed on BBU7 with some difference in the distal region of BBU7. However, the present cytogenetic map better anchors the RH-map on specific river buffalo chromosome bands. In addition, eleven loci were assigned for the first time in sheep to OAR6, noticeably extending the cytogenetic map on this important chromosome which encodes caseins. Two loci (TRAM1L1 and SNCA) mapped in sheep were unmapped in river buffalo in three different FISH experiments. Comparisons between integrated cytogenetic maps of BBU7/OAR6 (and BTA6) with human chromosome 4 (HSA4) revealed complex chromosome rearrangements differentiating these chromosomes.


Asunto(s)
Búfalos/genética , Cromosomas Humanos Par 4 , Cromosomas/genética , Mapeo Físico de Cromosoma , Ovinos/genética , Animales , Animales Domésticos , Bisbenzimidazol/metabolismo , Bromodesoxiuridina/metabolismo , Cromosomas Artificiales Bacterianos , Fluoresceína-5-Isotiocianato/metabolismo , Colorantes Fluorescentes/metabolismo , Humanos , Hibridación Fluorescente in Situ , Propidio/metabolismo , Rayos Ultravioleta
19.
Science ; 232(4749): 464-71, 1986 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-2421408

RESUMEN

Base sequence information can be stored in the local structure of right-handed double-helical DNA (B-DNA). The question arises as to whether a set of rules for the three-dimensional readout of the B-DNA helix can be developed. This would allow the design of synthetic molecules that bind DNA of any specific sequence and site size. There are four stages of development for each new synthetic sequence-specific DNA-binding molecule: design, synthesis, testing for sequence specificity, and reevaluation of the design. This approach has produced bis(distamycin)fumaramide, a synthetic, crescent-shaped oligopeptide that binds nine contiguous adenine-thymine base pairs in the minor groove of double-helical DNA.


Asunto(s)
ADN/metabolismo , Compuestos Organometálicos , Secuencia de Bases , Bisbenzimidazol/metabolismo , ADN/genética , Dactinomicina/metabolismo , Distamicinas/metabolismo , Ácido Edético/análogos & derivados , Ácido Edético/metabolismo , Hierro/metabolismo , Modelos Químicos , Netropsina/metabolismo , Pirroles/metabolismo , Relación Estructura-Actividad
20.
Science ; 228(4697): 346-8, 1985 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-2580350

RESUMEN

Cerebellar Purkinje neurons accumulated propidium iodide, granular blue, and horseradish peroxidase conjugated to wheat germ agglutinin but not unconjugated horseradish peroxidase, bisbenzimide, or Evans blue when these compounds were infused into the lateral cerebral ventricles of awake, unrestrained rats. Accumulation of propidium iodide by Purkinje neurons of the vermis was associated with a reproducible behavioral abnormality characterized by truncal tremor, ataxia, and nystagmus. Both the accumulation of propidium iodide in Purkinje cells and the behavioral abnormality were prevented by prior intracerebroventricular administration of ouabain or colchicine, drugs that block neuronal transport processes. The ability of cerebellar Purkinje neurons to extract small and large molecules from the cerebrospinal fluid has important implications for their physiology and pathology.


Asunto(s)
Líquido Cefalorraquídeo/fisiología , Células de Purkinje/metabolismo , Animales , Bisbenzimidazol/metabolismo , Dendritas/fisiología , Azul de Evans/metabolismo , Peroxidasa de Rábano Silvestre/metabolismo , Humanos , Masculino , Propidio/metabolismo , Propidio/farmacología , Células de Purkinje/fisiología , Ratas , Ratas Endogámicas , Temblor/inducido químicamente , Temblor/fisiopatología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda